Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

7.12

-0.58 (-7.53%)

At close: Apr 29, 2026, 4:00 PM EDT

7.11

-0.01 (-0.14%)

After-hours: Apr 29, 2026, 4:00 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
RNA Therapeutics	559.00K	43.26M	31.64M	21.66M	16.81M
RNA Therapeutics Growth	-98.71%	36.71%	46.12%	28.82%	124.73%
Total	559.00K	43.26M	31.64M	21.66M	16.81M
Total Growth	-98.71%	36.71%	46.12%	28.82%	124.73%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
UK	559.00K	43.11M	30.93M	20.94M	16.28M
UK Growth	-98.70%	39.37%	47.73%	28.63%	126.99%
Germany	-	144.00K	709.00K	715.00K	530.79K
Germany Growth	-	-79.69%	-0.84%	34.70%	72.02%
Total	559.00K	43.26M	31.64M	21.66M	16.81M
Total Growth	-98.71%	36.71%	46.12%	28.82%	124.73%

Source: S&P Global Market Intelligence.